J&J Warns of $400M Tariff Blow, Medtech Supply Chains in Focus
April 19, 2025
Johnson & Johnson has warned of a $400 million tariff cost in 2025, largely driven by China-related levies. The financial hit is expected to weigh
Johnson & Johnson has warned of a $400 million tariff cost in 2025, largely driven by China-related levies. The financial hit is expected to weigh
Despite political pressure and proposed tax incentives, most U.S. supply chain leaders see reshoring as too costly, with many warning tariffs could tip the economy
From mid-October, ships built or operated by China-linked entities face new U.S. port fees, sparking concern among importers and supply chain leaders about rising costs
A new national security probe into pharmaceutical imports could lead to sweeping tariffs, threatening cost increases across global supply chains and reshoring challenges for manufacturers.
Wells Fargo sees rising interest in supply chain finance programs as U.S. companies face mounting costs and uncertainty from shifting tariff policy under President Trump.
A new forecast warns of double-digit declines in U.S. container imports beginning in May, as retaliatory tariffs shake confidence and push retailers into inventory drawdown
As U.S. trade policy drives uncertainty for global supply chains, Novartis plans to build six factories and a new R&D hub to anchor production for
Smartphones and semiconductors escape Trump’s sweeping trade levies, offering relief to electronics supply chains—but uncertainty remains around China and North American imports. Electronics Exempted Under
As new tariff rules kick in, procurement leaders face a surge in documentation requirements—raising operational risk and exposing a critical weak spot in compliance workflows.
Pharmaceuticals could soon join the growing list of goods facing U.S. tariffs, with President Trump signaling a clampdown aimed at boosting domestic drug manufacturing—though the
Johnson & Johnson has warned of a $400 million tariff cost in 2025, largely driven by China-related levies. The financial hit is expected to weigh
Despite political pressure and proposed tax incentives, most U.S. supply chain leaders see reshoring as too costly, with many warning tariffs could tip the economy
From mid-October, ships built or operated by China-linked entities face new U.S. port fees, sparking concern among importers and supply chain leaders about rising costs
A new national security probe into pharmaceutical imports could lead to sweeping tariffs, threatening cost increases across global supply chains and reshoring challenges for manufacturers.
Wells Fargo sees rising interest in supply chain finance programs as U.S. companies face mounting costs and uncertainty from shifting tariff policy under President Trump.
A new forecast warns of double-digit declines in U.S. container imports beginning in May, as retaliatory tariffs shake confidence and push retailers into inventory drawdown
As U.S. trade policy drives uncertainty for global supply chains, Novartis plans to build six factories and a new R&D hub to anchor production for
Smartphones and semiconductors escape Trump’s sweeping trade levies, offering relief to electronics supply chains—but uncertainty remains around China and North American imports. Electronics Exempted Under
As new tariff rules kick in, procurement leaders face a surge in documentation requirements—raising operational risk and exposing a critical weak spot in compliance workflows.
Pharmaceuticals could soon join the growing list of goods facing U.S. tariffs, with President Trump signaling a clampdown aimed at boosting domestic drug manufacturing—though the
©Your trusted source for cutting-edge insights, best practice frameworks, and the latest news tailored exclusively for Supply Chain leaders.
Part of 360 Intelligence Ltd